Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment

    Investment - Page 3

    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Strides to exit investment in Arrow Pharma for over Rs 2000 crore

    Medical Dialogues Bureau30 Jan 2019 9:30 AM IST
    "Strides will receive AUD 300 million as upfront payment at the closure of the transaction, while the balance AUD 94 million to be deferred through a...
    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019

    Medical Dialogues Bureau17 Jan 2019 9:45 AM IST
    "We are investing Rs 500 crore to add 830 beds in 2019 across our three hospitals. This includes 232 beds in our Panchkula hospital which we have just...
    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Abbvie to record $4 billion impairment charges on Stemcentrx assets

    Medical Dialogues Bureau6 Jan 2019 9:00 AM IST
    The drugmaker acquired Rova-T through its $5.8 billion acquisition of Stemcentrx in 2016, as it aimed to enter the broad and lucrative arena of solid...
    IHH Healthcare open offer to acquistion of 26% stake in Fortis to commence on Dec 18

    IHH Healthcare open offer to acquistion of 26% stake in Fortis to commence on Dec 18

    Medical Dialogues Bureau14 Dec 2018 9:15 AM IST
    New Delhi: The open offer by Malaysian firm IHH Healthcare Berhad to acquire additional 26 per cent stake in Fortis Healthcare will commence on...
    Tivity Health to buy Nutrisystem for Rs 140 crores

    Tivity Health to buy Nutrisystem for Rs 140 crores

    Medical Dialogues Bureau11 Dec 2018 9:15 AM IST
    New Delhi: Tivity Health Inc said recently it would buy diet plan developer Nutrisystem Inc for $1.4 billion(Rs 140 crores) in cash and stock, as it...
    Fresenius plunges as health firm warns investment to hit profit

    Fresenius plunges as health firm warns investment to hit profit

    Medical Dialogues Bureau10 Dec 2018 9:00 AM IST
    Among its projects, the German company is developing copies of off-patent biotech drugs known as biosimilars and is also increasing output capacity in...
    Bayer reduces combined sales estimate for its experimental drugs

    Bayer reduces combined sales estimate for its experimental drugs

    Medical Dialogues Bureau8 Dec 2018 9:20 AM IST
    FRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
    AstraZeneca enters distribution agreement with Abbott for diabetes drug

    AstraZeneca enters distribution agreement with Abbott for diabetes drug

    Medical Dialogues Bureau8 Dec 2018 9:00 AM IST
    New Delhi: Drug firm AstraZenecaPharma India Friday said it has entered into a distribution agreement with Abbott Healthcare for distribution of...
    Alembic Pharma plans to get upto Rs 500 crore through NCDs

    Alembic Pharma plans to get upto Rs 500 crore through NCDs

    Farhat Nasim7 Dec 2018 9:50 AM IST
    New Delhi: Drug firm Alembic Pharma on Thursday said it plans to raise up to Rs 500 crore through issue of non-convertible debentures (NCDs) on...
    Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets

    Alembic Pharma gets USFDA nod for Candesartan Cilexetil tablets

    Medical Dialogues Bureau7 Dec 2018 9:15 AM IST
    New Delhi: Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Candesartan Cilexetil tablets, used...
    HUL, GSK Consumer shares rise 4 pc after boards approve merger

    HUL, GSK Consumer shares rise 4 pc after boards approve merger

    Medical Dialogues Bureau5 Dec 2018 9:57 AM IST
    New Delhi: Shares of Hindustan Unilever and Glaxo Smith Kline (GSK) Consumer Healthcare Monday surged 4 per cent on BSE after their boards approved...
    Chairman Anders Lonner dead: Karo Pharma

    Chairman Anders Lonner dead: Karo Pharma

    Medical Dialogues Bureau4 Dec 2018 9:00 AM IST
    STOCKHOLM: Speciality pharma firm Karo Pharma's Chairman Anders Lonner has died, the company said in a statement recently."Anders Lonner has suddenly...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok